期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Neurosurgical and pharmacological management of dystonia
1
作者 Ali Ahmed Mohamed Steven Faragalla +4 位作者 Asad Khan Garrett Flynn Gersham Rainone Phillip Mitchell Johansen Brandon Lucke-Wold 《World Journal of Psychiatry》 SCIE 2024年第5期624-634,共11页
Dystonia characterizes a group of neurological movement disorders characterized by abnormal muscle movements,often with repetitive or sustained contraction resulting in abnormal posturing.Different types of dystonia p... Dystonia characterizes a group of neurological movement disorders characterized by abnormal muscle movements,often with repetitive or sustained contraction resulting in abnormal posturing.Different types of dystonia present based on the affected body regions and play a prominent role in determining the potential efficacy of a given intervention.For most patients afflicted with these disorders,an exact cause is rarely identified,so treatment mainly focuses on symptomatic alleviation.Pharmacological agents,such as oral anticholinergic administration and botulinum toxin injection,play a major role in the initial treatment of patients.In more severe and/or refractory cases,focal areas for neurosurgical intervention are identified and targeted to improve quality of life.Deep brain stimulation(DBS)targets these anatomical locations to minimize dystonia symptoms.Surgical ablation procedures and peripheral denervation surgeries also offer potential treatment to patients who do not respond to DBS.These management options grant providers and patients the ability to weigh the benefits and risks for each individual patient profile.This review article explores these pharmacological and neurosurgical management modalities for dystonia,providing a comprehensive assessment of each of their benefits and shortcomings. 展开更多
关键词 Botulinum toxin Magnetic resonance imaging-guided focused ultrasound surgical ablation Deep brain stimulation Peripheral denervation surgery ANTIPSYCHOTICS
下载PDF
Surgical ablation of atrial fibrillation during mitral-valve surgery
2
《South China Journal of Cardiology》 CAS 2015年第1期58-59,共2页
Background Among patients undergoing mitral-valve surgery, 30 to 50% present with atrial fibrillation, which is associated with reduced survival and increased risk of stroke. Surgical ablation of atrial fibrillation h... Background Among patients undergoing mitral-valve surgery, 30 to 50% present with atrial fibrillation, which is associated with reduced survival and increased risk of stroke. Surgical ablation of atrial fibrillation has been widely adopted, but evidence regarding its safety and effectiveness is limited. 展开更多
关键词 surgical ablation of atrial fibrillation during mitral-valve surgery THAN
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部